Biznesradar bez reklam? Sprawdź BR Plus
Wiadomości PFE.US
28.66+0.46(+1.63%)(czas lokalny: 31.05.2024 16:00)Pfizer Inc.
WERSJA BETA
New York Stock Exchange Inc
Biznesradar bez reklam? Sprawdź BR Plus
Równo trzy lata temu na rynkach pojawiła się informacja, że
Pfizer ma szczepionkę przeciwko COVID-19. Indeksy giełdowe na wieść, że pandemia może
się szybko skończyć, rozpoczęły rajd, który trwał przez rok. Miliardy dolarów zarobione
na szczepionkach to już wspomnienie, co pokazują ostanie wyniki kwartalne.
Shares of Pfizer Inc. (NYSE: PFE) were down on Tuesday, after the company delivered lackluster results for the third quarter of 2023. Total revenues declined due to a drop in […]
The post Key takeaways from Pfizer’s (PFE) Q3 2023 earnings results first appeared on AlphaStreet.
Pfizer Inc. (NYSE: PFE) reported third quarter 2023 earnings results today. Revenues declined 42% year-over-year to $13.2 billion. The company reported a net loss of $2.3 billion, or $0.42 per […]
The post PFE Earnings: Key quarterly highlights from Pfizer’s Q3 2023 financial results first appeared on AlphaStreet.
Shares of Pfizer Inc. (NYSE: PFE) were down over 1% on Tuesday after the company delivered mixed results for the second quarter of 2023 and narrowed its guidance for the […]
The post Key takeaways from Pfizer’s (PFE) Q2 2023 earnings report first appeared on AlphaStreet.
Pfizer Inc. (NYSE: PFE) reported second quarter 2023 earnings results today. Revenues decreased 54% year-over-year to $12.7 billion. Reported net income declined 77% to $2.3 billion, or $0.41 per share, […]
The post PFE Earnings: All you need to know about Pfizer’s Q2 2023 earnings results first appeared on AlphaStreet.
Biznesradar bez reklam? Sprawdź BR Plus